MIDDLEWAY SURGERY
MIDDLEWAY, ST. BLAZEY, PAR
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 65 | 73 | 89.0% | |
| CKD 4 | 2008 | 107 | 114 | 93.9% | |
| CKD 5 | 2009 | 12 | 12 | 100.0% | |
| CKD 5 | 2010 | 19 | 23 | 82.6% | |
| CKD 5 | 2011 | 27 | 29 | 93.1% | |
| CKD 5 | 2012 | 33 | 35 | 94.3% | |
| CKD 5 | 2013 | 29 | 35 | 82.9% | |
| CKD003 | 2014 | 29 | 35 | 82.9% | |
| CKD003 | 2015 | 27 | 31 | 87.1% | |
| NM84 | 2016 | 47 | 75 | 62.7% | |
| NM84 | 2017 | 45 | 68 | 66.2% | |
| NM84 | 2018 | 41 | 58 | 70.7% | |
| NM84 | 2019 | 8 | 14 | 57.1% | |
| NM84 | 2020 | 5 | 12 | 41.7% | |
| NM84 | 2022 | 9 | 15 | 60.0% |
